Share Price
Ticker: KDEV List: NASDAQ OMX
Volume:
Press Releases
-
2018-04-26
Karolinska Development's Annual General Meeting 2018
-
2018-04-25
Interim Report January - March 2018
-
2018-04-16
Karolinska Development's portfolio company Aprea presents initial results from the ongoing phase Ib/II study with APR-246 and azacitidine for the treatment of Mutant Myelodysplastic Syndromes
News
-
2018-05-21
Karolinska Development's portfolio company Pharmanest appoints new CEO
-
2018-04-18
Karolinska Development's portfolio company Modus Therapeutics' sevuparin granted Rare Pediatric Disease Designation from FDA for the treatment of sickle cell disease
-
2018-04-06
Asarina Pharma announces the start of a clinical Phase IIB study in patients with premenstrual dysphoric disorder
